Key Financial Data Of Group

Daito Pharmaceutical Co., Ltd. - Filing #7588003

Concept As at
2022-08-31
2022-06-01 to
2022-08-31
2021-06-01 to
2022-05-31
As at
2022-05-31
As at
2021-08-31
2021-06-01 to
2021-08-31
Key financial data of group
Business results of group
Net sales
12,041,000,000 JPY
43,464,000,000 JPY
11,746,000,000 JPY
Ordinary profit (loss)
1,475,000,000 JPY
6,729,000,000 JPY
2,419,000,000 JPY
Profit (loss) attributable to owners of parent
946,000,000 JPY
4,668,000,000 JPY
1,825,000,000 JPY
Comprehensive income
1,238,000,000 JPY
4,821,000,000 JPY
1,745,000,000 JPY
Net assets
48,714,000,000 JPY
47,674,000,000 JPY
43,342,000,000 JPY
Total assets
69,422,000,000 JPY
64,939,000,000 JPY
58,729,000,000 JPY
Basic earnings (loss) per share
65.71
335.41
133.09
Diluted earnings per share
Equity-to-asset ratio
0.696 xbrli:pure
0.728 xbrli:pure
0.733 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.